Status:
WITHDRAWN
Rapid Screening for Olfactory Disorders in Covid-19 Infection
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Olfaction Disorders
COVID-19 Testing
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Loss of smell is very frequently found in Europe during Covid-19 attack. This symptom was not initially expected as part of the classic symptomatology. This loss of smell mainly concerns patients with...
Eligibility Criteria
Inclusion
- Subject presenting himself at the covid-19 screening centre set up by the city of Nice
Exclusion
- Presence of a sensory deficit (auditory or visual) preventing the subject from answering the questions perfectly during the olfactory test.
- Subject receiving cancer chemotherapy
Key Trial Info
Start Date :
January 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04696601
Start Date
January 8 2021
End Date
January 1 2023
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06003